Analysis of efficacy and safety in patients aged 65-75 years at randomization:Collaborative Atorvastatin Diabetes Study (CARDS)
- Neil, H Andrew W
- DeMicco, David A
- Luo, Don
- Betteridge, D John
- Colhoun, Helen M
- Durrington, Paul N
- Livingstone, Shona J
- Fuller, John H
- Hitman, Graham A
Publication date
January 2006
DOIAbstract
Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS)
Add to ORKG